Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The FDA and scientific priorities.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Califf RM;Califf RM
  • المصدر:
    Science (New York, N.Y.) [Science] 2022 Aug 26; Vol. 377 (6609), pp. 905. Date of Electronic Publication: 2022 Aug 25.
  • نوع النشر :
    Editorial
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
    • بيانات النشر:
      Publication: : Washington, DC : American Association for the Advancement of Science
      Original Publication: New York, N.Y. : [s.n.] 1880-
    • الموضوع:
      Armed Conflicts* ; COVID-19*/epidemiology ; COVID-19*/prevention & control ; Ecosystem* ; Life Expectancy*/trends ; Public Health* ; COVID-19 Drug Treatment*; Ukraine ; United States ; United States Food and Drug Administration
    • نبذة مختصرة :
      Earlier this year, when I was confirmed as the new commissioner of the US Food and Drug Administration (FDA), the world faced ongoing public health issues related to the pandemic and war in Ukraine, among other challenges. Most notably, the US is experiencing a flattening or decline in life expectancy compared with other high-income countries. As part of a wider effort to reverse this decline, relationships between FDA and the biomedical ecosystem should be reimagined to facilitate more effective translation of science into successful health interventions.
    • الموضوع:
      Date Created: 20220825 Date Completed: 20220829 Latest Revision: 20221207
    • الموضوع:
      20231215
    • الرقم المعرف:
      10.1126/science.ade5003
    • الرقم المعرف:
      36007042